The crystal structure is shown in the gure. Tables 1-3 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.
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Source of material
To a solution of 6-propyl-2-thiouracil-5-carbonitrile (1.95 g, 0.01 mol) in N,N-dimethylformamide (DMF) (8 mL), 1-bromopropane (1.23 g, 0.01 mol) and anhydrous potassium carbonate (1.38 g, 0.01 mol) were added and the mixture was stirred at room temperature for 12 h. Water (10 mL) was then gradually added and the mixture was stirred for further 10 min and allowed to stand for 1 h. The precipitated crude product was ltered, washed with cold water, dried and crystallized from aqueous ethanol to yield 1.54 g (65%) of Table 3 : Atomic displacement parameters (Å 2 ). 
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Experimental details
Cell re nement and data reduction were carried out by Bruker SAINT and SHELXS-97 [19, 20] . All hydrogen atoms were idealized and re ned using a riding model (AFIX 23 or AFIX 137 option of the SHELX-2008 program [19] ) except the nitrogen bonded H atom, which was re ned freely.
Discussion
Pyrimidine and pyrimidine-related non-nucleoside derivatives occupy a distinct and unique position in the eld of chemotherapy. The chemotherapeutic e cacy of pyrimidine derivatives is related to their ability to inhibit vital enzymes responsible for DNA biosynthesis as dihydrofolate reductase (DHFR), thymidylate synthetase (TSase), thymidine phosphorylase (TPase) and reverse transcriptase (RTase). Non-nucleoside pyrimidine-based derivatives have long been known as potent anticancer drugs [1] [2] [3] [4] . Large array of pyrimidine-based analogues have emerged as useful therapies against human immunode ciency viruses (HIV) [5] [6] [7] [8] , hepatitis B viruses (HBV) [9] , herpes simplex viruses (HSV) [10, 11] , in uenza viruses [12] and varicella-zoster virus (VZV) [13] . Moreover, several pyrimidine derivatives were reported to display antibacterial [14] [15] [16] [17] and antifungal [18] activities. Taking into consideration the diverse chemotherapeutic properties of pyrimidine-5-carbonitrile derivatives, we report herein the synthesis and the crystal structure of the title compound.
The asymmetric unit of the title structure contains only one molecule. The molecule is composed of a dihydropyrimidine ring attached to a propyl, sulfanylpropyl, cyano group and an oxygen atom. The molecular packing in the crystal structure is stabilized via one intermolecular hydrogen bond, of which O1 acts as the hydrogen bond acceptor and the NH group (N2) acts as the hydrogen bond donor. The distance of the interactions between N2-H1N2· · · O1 is 2.7438(13) Å and the angle is 179.00(3)°. Two symmetry related hydrogen bonds connect pairs of adjacent molecules to dimers.
